loader

Mindset Pharma Inc.

CNSX:MSET
1 min read

Mindset Pharma Inc is a drug discovery and development company focused on creating psychedelic medicines to treat neurological and psychiatric disorders.

Mindset Pharma to Participate in Upcoming Conferences in December 2022

Mindset Pharma CEO, James Lanthier Issues Letter to Shareholders

Mindset Pharma and PharmAla Biotech Enter into Exclusive Sales Agreement

Mindset Pharma and PharmAla Enter into Exclusive Sales Agreement for the Sale and Distribution of Pharmaceutical Grade Psilocybin

Mindset Pharma Presents Poster at Neuroscience 2022 Highlighting Preclinical Data on MSP-1014, its Psilocybin-like Lead Drug Candidate

Mindset Pharma Announces Poster Presentations at Two Upcoming Scientific Conferences

Mindset Pharma Selects Lead Clinical Candidates From "Family 2" of its Next Generation Psychedelic Drug Portfolio

Mindset Pharma Receives Scientific Advice from UK Regulator Facilitating Advancement of Phase 1 First-In-Human Clinical Trial Plan for Its Lead Clinical Candidate, MSP-1014

Mindset Pharma Files National Patents Protecting Family 1 Application in 16 Different Countries

Mindset Pharma Further Expands its IP Portfolio with Three Additional Non-Tryptamine Families of Next-Generation Psychedelic Compounds

Latest News

More News

Latest News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES